IntegriChain announces that it was recognized in two areas of Gartner’s Hype Cycle for Life Sciences Commercial Operations 2019, which is available on Gartner.com. IntegriChain is included as a sample vendor for both Revenue Management and Life Sciences Commercial Analytics.
IntegriChain announces the expansion of the Revenue Analytics Collaborative, an industry networking group of 800 Government, Commercial, GTN and Now Trade/Channel members spanning 225+ Life Sciences manufacturers, as well as the launch of RACollab.org, a new digital community for knowledge sharing, benchmarking and collaboration.
IntegriChainhas been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2019 in the large-sized company category.
IntegriChain has now implemented more than 10 artificial intelligence/machine learning (AI/ML) models and predictive analytics to its ICyte Platform. IntegriChain’s advancements in AI/ML and predictive analytics were recently highlighted in a Gartner report, “Life Science CIOs Can Accelerate Commercial Effectiveness With New Applications of Artificial Intelligence,” which is available on Gartner.com.
Co-Founder and EVP, Product & Strategy Josh Halpern, will present “Leveraging Data Science to Improve Patient Adherence" at the CBI Patient Support Services Congress June 19.
Jen Sharpe, IntegriChain's Executive Advisor for the Revenue Analytics Collaborative, will present at the CBI Financial Strategies and Accounting for Bioscience Companies on “Ensuring Best Practices in GTN Accounting and Forecasting: Copay, Coverage Gap and Returns — Three Pain Points Resolved."
IntegriChain opens registration for the Access Insights Conference 2019, formerly known as the IntegriChain User Conference. The Access Insights Conference will be held October 21-23, 2019, in the Atlanta/Buckhead area.
IntegriChain merges with daVIZta, a leading provider of revenue analytics software, including gross-to-net (GTN) automation and government pricing solutions -- key challenges for commercial-stage life sciences companies to ensure access to new and existing therapies -- and serves as a trusted partner to large, mid-tier, and emerging life sciences manufacturers.
IntegriChain’s Executive Vice President, Joshua Halpern, will present a company overview at Baird's 4th Annual Private Company Technology & Services Conference on Wednesday, February 13 in New York.
IntegriChain launches the Data Refinery for its Patient and Distribution solutions, capitalizing on fully automated metadata processes and advanced machine learning to deliver Data Enrichment 3.0, the next-generation of data enrichment, to improve the efficiency, consistency, accuracy, and adaptability of key commercial datasets for specialty and retail bio/pharma brands.
(formerly the IntegriChain User Conference)
October 21-23, 2019 | Buckhead/Atlanta